Stock listing
SIGHT Stock Price, News, Filings & Events — Gensight Biologics Sa
Selected listing: SIGHT · EURONEXT · EUR · FR
This page tracks Gensight Biologics Sa's SIGHT:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SIGHT:EURONEXT. SIGHT:EURONEXT is the stock-level entry point for investors researching Gensight Biologics Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Gensight Biologics Sa is a public company listed under the ticker SIGHT on the French market. The company has a market capitalization of approximately €22.3 million. Gensight focuses on developing innovative gene therapies for retinal diseases.
- Ticker
- SIGHT:EURONEXT
- Asset type
- Stock
- Market cap
- $35.2M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- EURONEXT
- Currency
- EUR
Gensight Biologics Sa SIGHT:EURONEXT stock context
This page tracks Gensight Biologics Sa's SIGHT:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SIGHT:EURONEXT. SIGHT:EURONEXT is the stock-level entry point for investors researching Gensight Biologics Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Gensight Biologics Sa is a public company listed under the ticker SIGHT on the French market. The company has a market capitalization of approximately €22.3 million. Gensight focuses on developing innovative gene therapies for retinal diseases.
Latest news from Gensight Biologics Sa
GenSight Biologics S A : Reports Interim Financial Results for the First Half of 2026 and Provides Business Updates
September 29, 2026
GenSight Biologics Provides September 2026 Business Updates
September 8, 2026
GenSight Biologics Reports Cash Position as of June 30, 2026, and Provides Business Updates
July 8, 2026
GenSight Biologics Announces the Results of its Combined General Meeting of May 19, 2026
May 20, 2026
GenSight Biologics to Hold its Combined General Meeting on May 19, 2026
May 18, 2026
Research Gensight Biologics Sa
Gensight Biologics Sa investor report
Review AI stock analysis and investor report context for SIGHT:EURONEXT.
Gensight Biologics Sa company profile
View the public company page for Gensight Biologics Sa on 6ix.
Gensight Biologics Sa news
Read company news and market updates connected to Gensight Biologics Sa.
Gensight Biologics Sa investor events
Find investor webinars, events, and replay context for Gensight Biologics Sa.
Alternate listings
0RIM:LSE
GB · EUR
Alternate listing for Gensight Biologics Sa; the primary context on this page is SIGHT:EURONEXT.
G49N:GETTEX
DE · EUR
Alternate listing for Gensight Biologics Sa; the primary context on this page is SIGHT:EURONEXT.
A2ANGZ:LSX
DE · EUR
Alternate listing for Gensight Biologics Sa; the primary context on this page is SIGHT:EURONEXT.
A2ANGZ:LS
DE · EUR
Alternate listing for Gensight Biologics Sa; the primary context on this page is SIGHT:EURONEXT.
SIGHTP:AQUISEU
GB · EUR
Alternate listing for Gensight Biologics Sa; the primary context on this page is SIGHT:EURONEXT.
GSGTF:OTC
US · USD
Alternate listing for Gensight Biologics Sa; the primary context on this page is SIGHT:EURONEXT.
SIGHTP:AQUISUK
GB · EUR
Alternate listing for Gensight Biologics Sa; the primary context on this page is SIGHT:EURONEXT.
G49N:DUS
DE · EUR
Alternate listing for Gensight Biologics Sa; the primary context on this page is SIGHT:EURONEXT.
G49N:FWB
DE · EUR
Alternate listing for Gensight Biologics Sa; the primary context on this page is SIGHT:EURONEXT.
G49N:HAM
DE · EUR
Alternate listing for Gensight Biologics Sa; the primary context on this page is SIGHT:EURONEXT.
G49N:MUN
DE · EUR
Alternate listing for Gensight Biologics Sa; the primary context on this page is SIGHT:EURONEXT.
G49N:SWB
DE · EUR
Alternate listing for Gensight Biologics Sa; the primary context on this page is SIGHT:EURONEXT.